Mechanisms of action of gabapentin

Revue Neurologique

Volumn 153, Issue SUPPL. 1, 1997, Pages

  Taylor, Ch P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; CALCIUM CHANNEL; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; NIPECOTIC ACID; PHENYTOIN; TIAGABINE; VIGABATRIN;

4 AMINOBUTYRIC ACID RELEASE; ANTICONVULSANT ACTIVITY; DRUG RECEPTOR BINDING; EPILEPSY; EPILEPTOGENESIS; GABAERGIC SYSTEM; NONHUMAN; REVIEW;

EID: 84892674544     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. BARTOSZYK G.D., MEYERSON N., REIMANN W., SATZINGER G., VON HODENBERG A. GABAPENTIN. In: MELDRUM B.S. AND PORTER R.J. (EDS). (1986). New Anticonvulsant Drugs. London, John Libbey, pp. 147-163.
2. BLOMS-FUNKE P., LÖSCHER W. (1996). The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons. Europ J Pharmacol, 316 : 211-218.
3. B receptor pharmacology. Annu Rev Pharmacol Toxicol, 33 : 109-147.
4. BRESLOW M.F., FRANKHAUSER M.P., POTTER R.L., MEREDITH K.E., MISIASZEK J., HOPE D.G. (1989). Role of gamma-aminobutyric acid in antipanic drug efficacy. Am J Psychiat, 146 : 353-356.
5. CHADWICK D. GABAPENTIN: CLINICAL USE. In:LEV R.H., MATTSON R.H. AND MELDRUM B.S. (EDS). (1995). Antiepileptic Drugs. New York, Raven Press, pp. 851-856.
6. DEVOR M. (1996). Pain mechanisms. Neuroscientist, 2 : 233-244.
7. DURING M., RYDER K.M., SPENCER D.D. (1995). Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature, 376 : 174-177.
8. ERLANDER M.G., TILLAKARATNE N.J., FELDBLUM S., PATEL N.,TOBIN A.J. (1991). Two genes encode distinct glutamate decarboxylases. Neuron, 7 : 91-100.
9. ERLANDER M.G., TOBIN A.J. (1991). The structural and functional heterogeneity of glutamic acid decarboxylase: A review. Neurochem Res, 16 : 215-226.
10. FARIELLO R.G. VALPROIC ACID: MECHANISMS OF ACTION. LEVY R.H., MATTSON R.H. AND MELDRUM B.S. (EDS). (1995). Antiepileptic Drugs. New York, Raven Press, pp. 581-588.
11. FICHTER N., TAYLOR C.P., FEUERSTEIN T.J. (1996). Nipecotate-induced GABA release from slices of the rat caudato-putamen: effects of gabapentin. N-S Arch Pharmacol, 354 : R35 (Abstract).
12. 2delta subunit of a calcium channel. J Biol Chem, 271 : 5768-5776.
13. GOLDLUST A., SU T., WELTY D.F., TAYLOR C.P., OXENDER D.L. (1995). Effects of the anticonvulsant drug gabapentin on enzymes in the metabolic pathways of glutamate and GABA. Epilepsy Res, 22 : 1-11.
14. GÖTZ E., FEUERSTEIN T.J., MEYER D.K. (1993). Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Drug Res, 43 : 636-638.
15. GRAM L., LARSON O.M., JOHNSEN A., SCHOUSBOE A. (1989). Experimental studies of the influence of vigabatrin on the GABA system. Brit J Clin Pharmacol, 27 : 13S-18S.
16. 3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Europ J Pharmacol, 244 : 303-309.
17. HONMOU O., KOCSIS J.D., RICHERSON G.B. (1995a). Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neuron in vitro. Epilepsy Res, 20 : 193-202.
18. HONMOU O., OYELESE A.A., KOCSIS J.D. (1995b). The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res, 692 : 273-277.
19. KAWASAKI H., MATTIA D., ZONA C., AVOLI M. (1995). Effects induced by gabapentin on the electrophysiological properties of bursting neurons in the rat subiculum in vitro. Soc Neurosci Abstr, 21 : 2117.
20. KEYNAN S., KANNER B.I. (1988). Gamma-aminobutyric acid transport in reconstituted preparations from rat brain: coupled sodium and chloride fluxes. Biochem, 27 : 12-17.
21. KOCSIS J.D., HONMOU O. (1994). Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci Lett, 169 : 181-184.
22. LIRON Z., WONG E., ROBERTS E. (1988). Studies on uptake of gamma-aminobutyric acid by mouse brain particles; toward the developement of a model. Brain Res, 444 : 119-132.
23. LÖSCHER W., HONACK D., TAYLOR C.P. (1991). Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett, 128 : 150-154.
24. MACDONALD R.L. CARBAMAZEPINE: MECHANISMS OF ACTION. LEVY R.H., MATTSON R.H. AND MELDRUM B.S. (EDS) (1995a). Antiepileptic Drugs. New York, Raven Press, pp. 491-498.
25. MACDONALD R.L. BENZODIAZEPINES: MECHANISMS OF ACTION. LEVY R.H., MATTSON R.H. AND MELDRUM B.S. (EDS) (1995b). Antiepileptic Drugs. New York, Raven Press, pp. 695-704.
26. A receptor channels. Annu Rev Neurosci, 17 : 569-602.
27. MARTIN D., MARTIN S.B., WU S.J., ESPINA N. (1991). Regulatory properties of brain glutamate decardoxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J Neurochem, 11 : 2725-2731.
28. MELDRUM B.S. GABA AND OTHER AMINO ACIDS. FREY M.M. AND JANZ D. (EDS) (1985). Antiepileptic Drugs. Berlin, Springer-Verlag, pp. 153-188.
29. OCHI S., LIM J.Y., RAND M.N., DURING M.J., SAKATANI K., KOCSIS J.D. (1993). Transient presence of GABA in astrocytes of the developing optic nerve. Glia, 9 : 188-198.
30. PASLAWSKI T., THEIT D., BAKER G.B., GEORGE M., COUTTS R.T. (1996). The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacol, 127 : 19-24.
31. PETROFF O.A.C., ROTHMAN D.L., BEHAR K.L., LAMOUREUX D., MATTSON R.H. (1996). The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol, 39 : 95-99.
32. PETTY F, SHERMAN A.D. (1984). Plasma GABA levels in psychiatric illness. J Affect Disord, 6 : 131-138.
33. PILC A., LLOYD K.G. (1984). Chronic antidepressants and GABA « B » receptors: a GABA hypothesis of antidepressant drug action. Life Sci, 35 : 2149-2154.
34. PIN J.P., BOCKAERT J. (1989). Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J Neurosci, 9 : 648-656.
35. 35S]t-butyl bicyclophosphorothionate binding by convulsant agents in primary cultures of cerebellar neurons. Devl Brain Res, 73 : 85-90.
36. RADULOVIC L.L., TAYLOR C.P., WALKER R. (1995).The preclinical pharmacology, pharmacokinetics and toxicology of gabapentin. Drugs of today, 31 : 597-611.
37. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. Mol Pharmacol, 40 : 756-765.
38. RAO M.L., CLARENBACH P., VAHLENSIECK M., KRAETZSCHMAR S. (1988). Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm, 73 : 129-134.
39. ROCK D.M., KELLY K.M., MACDONALD R.L. (1993). Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res, 16 : 89-98.
40. 67 cDNAs in retroviral vectors produce and release GABA. J Neurochem, 61 : 768-771.
41. SATZINGER G. (1994). Antiepileptics from gamma-aminobutyric acid. Drug Res, 44 : 261-266.
42. SINGH L., FIELD M.J., FERRIS P., HUNTER J.C., OLES R.J., WILLIAMS R.G., WOODRUFF G.N. (1996). The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacol, 127 : 1-10.
43. 35S]t-butyl bicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recongition sites. Mol Pharmacol, 23 : 326-336.
44. SU T., LUNNEY E., CAMPBELL G., OXENDER D.L. (1995). Transport of gabapentin, a gamma-amino acid drug, by system L a-amino acid transporters: a comparative study in astrocytes, synaptosomes and CHO cells. J Neurochem, 64 : 2125-2131.
45. 3H]-gabapentin binding to a novel site in rat brain: homogenate binding studies. Europ J Pharmacol, 244 : 293-301.
46. 3H]tiagabine (NNC 05-328) to the GABA uptake carrier. Brain Res, 647 : 231-241.
47. SUZDAK P.D., JANSEN J.A. (1995). A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia, 35 : 612-626.
48. SZERB J.C. (1982). Effect of nipecotic acid, a gamma-aminobutyric acid transport inhibitor, on the turnover and release of gamma-aminobutyric acid in rat cortical slices. J Neurochem, 850-858.
49. TAPIA R., SALAZAR P. (1991). Glutamate decarboxylase activity in the substantia nigra and the hippocampus of rats microinjected with inhibitors of the enzyme. Neurochem Res, 16 : 263-267.
50. TAYLOR C.P., VARTANIAN M.G., ANDRUSZKIEWIEWICZ R., SILVERMAN R.B. (1992). 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res, 11 : 103-110.
51. + channels in a voltage- dependent manner but gabapentin does not. Soc Neurosci Abstr, 23 : 1631.
52. TAYLOR C.P. GABAPENTIN: MECHANISMS OF ACTION. In: LEVY R.H., MATTSON R.H. AND MELDRUM B.S. (EDS). (1995). Antiepileptic Drugs. New York, Raven Press, Ltd. pp. 829-841.
53. 2+] solutions. Epilepsia, 37 : 21 (Abstract).
54. 3H]-gabapentin binding may label a system-L like neutral amino acid carrier in brain. Europ J Pharmacol, 247 : 341-345.
55. TUNNICLIFF G., RAESS B.U. (EDS). (1991). GABA Mechanisms in Epilepsy. Wiley-Liss, New York.
56. VOLLMER K.O., VON HODENBERG A., KOELLE E.U. (1986). Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim Forsch Drug Res, 36 : 830-839.
57. WAMILL A.W., MCLEAN M.J. (1994). Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res, 17 : 1-11.